肝癌Ⅳ期患者黄疸出现后生存期的测定及意义

摘要

Objective To determinate the survival period of stage IV hepatocellular carcinoma with jaundice. Meth-ods The survival period of 78 cases with stage IV primary liver cancer with jaundice was observed. Results The survival period of the patients' AFP <400 μg / L was 10 days to 4 months and the median survival time was 25 days. The survival period of the patients, AFP>400μg/L was 3 days to 20 days and the median survival time was 10 days. Conclusion AFP is an important index of the survival period of stage IV primary liver cancer with jaundice.%目的 测定原发性肝癌Ⅳ期患者黄疸出现后的生存期,并探讨其意义.方法 对住院的78例因肝功能衰竭死亡的原发性肝癌Ⅳ期患者,进行黄疸出现后生存期测定.结果 AFP(甲胎蛋白)＜400μg/L原发性肝癌Ⅳ期患者,黄疸出现后最长生存期4个月,最短生存期10天,中位生存期25天；AFP＞400μg/L原发性肝癌Ⅳ期患者,黄疸出现后最长生存期20天,最短生存期3天,中位生存期10天..结论 AFP＞400μg/L原发性肝癌Ⅳ期患者生存期比AFP＜400μg/L原发性肝癌Ⅳ期患者短.测定原发性肝癌Ⅳ期患者黄疸出现后的生存期,可预先告知患者亲属做好善后准备,并对患者进行劝慰,让其尊严离世,同时采取相应治疗及护理措施.